Clinical Trial Scheme of Tanreqing Capsules in the Treatment of COVID-19

Summary

This study was conducted in a randomized, double-blind, placebo-controlled, multicenter clinical trial design. Two groups were designed, the experimental group and the placebo control group. Patients in both groups received basic treatment with vitamin C effervescent tablets. Tanreqing capsule was added to basic treatment in the experimental group, and placebo was added to basic treatment in the control group. The treatment course was 7 days, and the observation period was set to 7 days, with a daily visit.

Timeline

Start

2022-03-28

Primary completion

2022-06-02

Completion

2022-08-31

Drugs

Indications